WHC
GH icon

Wulff, Hansen & Co’s Guardant Health GH Stock Holding History

Wulff, Hansen & Co’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$478K Hold
3,185
– – 0.37% 66
2026
Q1 		$294K Hold
3,185
– – 0.3% 83
2025
Q4 		$325K Buy
+3,185
New +$285K 0.27% 85
2022
Q4 		– Sell
-3,860
Closed -$208K – 83
2022
Q3 		$208K Buy
+3,860
New +$198K 0.26% 76

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Wulff, Hansen & Co's GH Position: Q2 2026 in Review

Wulff, Hansen & Co held its Guardant Health (GH) position steady in Q2 2026 at 3,185 shares worth $478K. The position accounts for 0.37% of the portfolio, ranked #66.

Wulff, Hansen & Co first reported a position in GH in Q3 2022 and has held it in 4 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Wulff, Hansen & Co held 3,185 shares of Guardant Health worth $478K as of Q2 2026.
  • Wulff, Hansen & Co left its Guardant Health share count unchanged in Q2 2026.
  • Guardant Health made up 0.37% of Wulff, Hansen & Co's portfolio in Q2 2026, its #66 holding.
  • Wulff, Hansen & Co first reported a position in Guardant Health in Q3 2022 and has held it in 4 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Wulff, Hansen & Co's 13F filing for Q2 2026, filed 5 Aug 2026.